Jaguar health reports 2020 financial results and business updates

Mytesi® net sales and gross sales grew 64% and 148%, respectively, in 2020 compared to 2019 san francisco, ca / accesswire / march 31, 2021 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") today reported consolidated financial results for the year ended december 31, 2020. 2020 company financial results: mytesi® net product revenue: 2020 mytesi net sales were approximately $9.3 million, and mytesi gross (non-gaap) sales were approximately $20.4 million, an increase of 64% and 148%, respectively, year over year.
JAGX Ratings Summary
JAGX Quant Ranking